Home Wiki

GoodRX sells health information to advertisers

Last updated View on consumerrights.wiki ↗

Work in progress
This article has been flagged for additional work. Treat its claims as provisional.
Stub
This article is a stub. The wiki community is still building it out.
Verification concerns
Editors have raised concerns about the verifiability of one or more claims.
Contents6
  1. Background
  2. [Incident]
  3. GoodRX's response
  4. Lawsuit
  5. Consumer response
  6. References

This article is a stub. You can help by expanding it.

A moderator needs to check the page before this notice can be removed. Visit the noticeboard or the #appeals channel in either Zulip or Discord to request removal.
More info ▼

An article may be flagged as a stub when it is missing major elements needed to make it useful to a reader. You can help by adding missing sections, verifiable sources, relevant company policies and communications, etc. to make the article more complete.

⚠️This article has been marked as incomplete. Sourcing or verifiability needs additional work.
In particular:
  1. Needs to use Template:Cite web for references
A moderator needs to check the page before this notice can be removed. Visit the noticeboard or the #appeals channel in either Zulip or Discord to request removal.
More info ▼

Articles must provide verifiable, credible evidence for their claims and avoid relying on forum posts, personal blogs, or other unverifiable sources. You can help by replacing weak citations with reputable reporting, corporate communications, receipts, repair logs, or independent investigative coverage that demonstrates the systemic relevance required by the Mission statement and Moderator Guidelines.

The FTC took enforcement action against GoodRx Holdings Inc. for sharing consumers' sensitive health information with advertising platforms in violation of its privacy promises and the Health Breach Notification Rule. Since at least 2017, the company shared users' personal health data—including prescription medications and health conditions—with Facebook, Google, Criteo, and other third parties despite repeatedly promising it would never do so. GoodRx agreed to pay a $1.5 million civil penalty and is prohibited from sharing user health data with applicable third parties for advertising purposes.[1]

Note that this is not in violation of HIPAA as the service that GoodRX provides is not technically covered under HIPAA law, due to this type of service not existing at the time of the writing of HIPAA law. [2] Of which they falsely stated that they are covered under with the intention to mislead customers that they have a standard of privacy. [3]

Background

GoodRX is a free prescription drug savings program designed to take advantage of how prescriptions are managed in the U.S. pharmacy system through the use of Pharmacy Benefit Managers. [4][5]


[Incident]

Change this section's title to be descriptive of the incident.

Impartial and complete description of the events, including actions taken by the company, and the timeline of the incident coming to the public's attention.


Add your text below this box. Once this section is complete, delete this box by clicking on it and pressing backspace.

From at least 2017 through February 2020, GoodRx shared consumers’ sensitive personal health information with third-party advertising platforms, including Facebook, Google, and Criteo. The shared data included prescription medication names, health conditions, and other intimate details that could reveal medical conditions when combined with browser information. GoodRx embedded tracking technologies—such as a Facebook JavaScript pixel—on its platform to facilitate this sharing for advertising purposes. This occurred despite the company repeatedly promising users in its privacy policy and public statements that it would never share such health data.

Consumer Reports reported the incident in March of 2020.[6] A few days later, they stopped sending prescription data to Facebook. [7]

GoodRX's response

The company agreed to the settlement without admitting wrongdoing. [8][9]

Lawsuit

In November 2024, independent pharmacies filed at least three class action lawsuits against GoodRX and major pharmacy benefit managers. [10] The lawsuits also allege that agreements using GoodRX's software suppressed reimbursements for generic drugs and violated the Sherman Antitrust Act, of which practices amount to price fixing which harms small pharmacies while benefiting pharmacy benefit managers and their affiliates. [11]GoodRX also settled upon these lawsuits without admitting wrongdoing. [8]

Consumer response

References

Filed under